Flannagan to leave Tower after strategic review, asset sales

Flannagan to leave Tower after strategic review, asset sales
March 21 (BusinessDesk) – Rob Flannagan is to step down as managing director of Tower following the completion of the listed insurer’s strategic review and sale of its health and investment units. Flannagan will work out the 12 months of his notice, the company said in a statement. He has led Tower for seven years. “Tower now has a refreshed board with a clear direction of where it wishes Tower to be in the future,” he said. “It is time to step aside to allow a new leader to guide the company in its preferred direction.” Tower embarked on a...